Eyeworld Daily News

EW SHOW DAILY 64 T omorrow morning, an oph- thalmic version of the show "MythBusters" will be pre- sented bright and early dur- ing a unique CME breakfast symposium focused on dispelling commonly held myths surrounding the true impact of inflammation on cataract surgery outcomes. Here are a few of the myths that the leading faculty, led by moderator Ed Holland, MD, will try to dispel during this program: • Low to moderate ocular inflamma- tion has no significant impact on visual quality and patient satisfac- tion following cataract surgery. • I only really need to worry about inflammation after cataract sur- gery in patients with pre-existing risk factors like diabetes or retinal- vascular problems. • Understanding the inflammatory cascade isn't relevant to the man- agement of my patients undergo- ing cataract surgery. • Steroids alone can control pain and inflammation after cataract surgery. • We can never eliminate clinically significant inflammation. Exciting usage of audience response systems with program attendees will help measure how well these myths were "busted." Other interesting data have al- ready been acquired from a survey conducted a few days ago with all ASCRS members who have preregis- tered for this symposium. One subject on the survey covered the acceptable level of inflammation on postop day one. Respondents were largely split over whether this ac- ceptable level was trace to 1+ cell and flare, or 1+ to 2+ cell and flare. This topic will be reviewed in detail by the program faculty. Another key piece of data from the preregistrant survey covered what course of care is altered in cases with known risk factors for inflammation (Figure 1). More than 50% of respondents stated they would lengthen the duration of the anti-in- flammatory therapy and use differ- ent anti-inflammatory medications. These topics will also be reviewed in the program. A final point covered was the impact of low-to-moderate ocular in- flammation on outcomes in refrac- tive IOL patients. More than two-thirds of respondents indicated that this amount of inflammation significantly affects not only visual acuity, visual quality and recovery times, but it also impacts patient comfort and satisfaction, which is so critical to the success of a refractive IOL practice. Highlights of this program in- clude the following: • Bonnie An Henderson, MD, will discuss data showing that any postop pain is the most significant predictor of patient dissatisfaction with care and is associated with low ratings for the quality of the surgical experience. She will re- view whether and how surgeons can predict which patients are at risk for corneal or macular edema after cataract surgery. • Clara Chan, MD, will discuss how surgical stress begins even before the incision. Using an NCAA bas- ketball tournament analogy, she will talk about defensive tactics to prevent and interrupt the inflam- matory cascade that occurs in re- sponse to surgical stress. • David Goldman, MD, will review the scientific rationale behind initiation and dosing of corticos- teroids and NSAIDs and share his personal regimen for prevention of postoperative inflammation. This CME symposium, "Under- standing and Managing the Impact of Cataract Surgery Stress on Ocular Inflammation: Uveitis, CME, and Corneal Edema," will take place in the Moscone Center, EyeWorld Theater (Gateway Ballroom), on Sunday morning, with a 6:00 a.m. registration and breakfast, and a 6:30 a.m. start time for the one-hour symposium. This program is sup- ported by an unrestricted grant from Alcon (Fort Worth, Texas). Onsite registration is available. EW Saturday, April 20, 2013 EyeWorld Education MythBusters comes to ophthalmology by Brad Fundingsland EyeWorld Educational Development Group Figure 1. In a recent survey, symposium preregistrants were asked how they would alter the course of care for a patient with known risk factors for inflammation who is undergoing cataract surgery. Street Talk What are you most looking forward to at this meeting? "All the sessions on cataract surgery, because I absolutely love cataract surgery." – Sergio Acevedo, MD, Santiago, Chile "I work in refractive surgery, so I look forward to all refractive sessions on LASIK and PRK and surgery of the anterior segment." – Mario Canas, MD, Santiago, Chile "Learning about the delivery of new technolo- gies that will maximize benefit to my patients; that's what I'm looking forward to the most." – Alan Carlson, MD, Durham, N.C.

• Cover